Rare diseases
Investigational molecules
Locations
Back to Italy2 391 clinical trials in Milan, Italy across 15 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on Alnuctamab and Drug Combination for Patients with Relapsed or Refractory Multiple Myeloma
ItalyStudy of Farletuzumab Ecteribulin vs. Chemotherapy for Women with Platinum-resistant High-grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
ItalyStudy of VRDN-001 for Patients with Thyroid Eye Disease Who Did Not Respond to Previous Treatment
ItalyStudy of Emrusolmin for Treating Adults with Multiple System Atrophy
ItalyStudy on Ribociclib, Topotecan, and Temozolomide for Children and Young Adults (12 months - 21 years) with Relapsed or Refractory Neuroblastoma and Solid Tumors
ItalyStudy of Durvalumab, Tremelimumab, and Lenvatinib with TACE for Patients with Liver Cancer (Hepatocellular Carcinoma)
ItalyStudy on Long-Term Safety of Donidalorsen for Patients with Hereditary Angioedema
ItalyStudy on Tafasitamab and Lenalidomide with Standard Therapy for Newly Diagnosed High-Risk Diffuse Large B-Cell Lymphoma Patients
ItalyLong-Term Study of BI 1015550 for Patients with Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis
ItalySafety and effectiveness study of DYNE-101 in patients with Myotonic Dystrophy Type 1 (DM1)
ItalyStudy on the Effects of AR1001 (Mirodenafil Dihydrochloride) for Patients with Early Alzheimer's Disease
ItalyStudy on the Effectiveness and Safety of OTL-203 for Patients with Hurler Syndrome (MPS-IH) Compared to Standard Treatment with Stem Cell Transplantation
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on colorectal cancer, breast cancer prevention, and advanced solid tumors. Studies include evaluation of novel therapeutic approaches and diagnostic methods.
Research emphasizes personalized treatment approaches and preventive interventions for high-risk patients.
Research initiatives targeting neurodegenerative conditions and chronic headache disorders, with studies examining innovative therapeutic approaches.
Focus on developing targeted therapies and understanding disease mechanisms.
Studies investigating treatments for autoimmune conditions and infectious diseases, including preventive approaches and therapeutic interventions.
Emphasis on developing novel preventive strategies and therapeutic solutions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
